Research article

Attendance of psychosocial teen clubs and self-reported antiretroviral medication adherence: a cross section study of adolescents with perinatal HIV in the Kingdom of Lesotho

  • Received: 16 May 2021 Accepted: 05 July 2021 Published: 02 August 2021
  • Background 

    To address the problem of poor adherence among adolescents with perinatal HIV (PHIV), all clinics in Lesotho offer adolescent-friendly services and psychosocial support to improve their overall health outcomes and adherence. As a result, most adolescents with PHIV attend Teen Clubs as part of the package of youth-friendly HIV services. This study set out to determine whether attending Teen Clubs facilitates treatment adherence among adolescents with PHIV.

    Methods 

    In this cross-sectional study, data were collected from 130 adolescents aged 10–19 years who were aware of their HIV status and had attended three or more Teen Club sessions in selected clinics in rural district in Lesotho. Adherence was measured through self-report of last pills missed, based on the 7-days recall of pills taken. Descriptive statistics were used to analyse the data.

    Results 

    The median age of adolescents was 15 years, 56% were female, 37.7% were orphans, 41% were being cared for by their grandparents, 6.9% were living with siblings with no adult figure, and two were living on their own. The majority (93%) reported optimal adherence, 92% had not missed a clinic appointment in the past 30 days, and 74.4% knew that if they skipped doses, the viral load would increase and they would get sick. Over half (56%) had been reminded by their caregivers to take their medication and 96% talked to their caregivers regularly about their medication.

    Conclusion 

    A supportive environment provided through the Teen Clubs and in the home were the main facilitators for adherence. Strategies to improve adherence among adolescents should consider the importance of the involvement of caregivers in the adolescents' visits to their clinic.

    Citation: Sphiwe Madiba, Ntaoleng Mohlabane. Attendance of psychosocial teen clubs and self-reported antiretroviral medication adherence: a cross section study of adolescents with perinatal HIV in the Kingdom of Lesotho[J]. AIMS Public Health, 2021, 8(3): 541-552. doi: 10.3934/publichealth.2021044

    Related Papers:

    [1] Philip Boakye, Adwoa Safowaa . Prevalence and predictors of viral load suppression in adults living with HIV in the western region of Ghana: A cross-sectional study. AIMS Public Health, 2023, 10(2): 469-479. doi: 10.3934/publichealth.2023033
    [2] Tyler C. Smith MS PhD, Besa Smith MPH PhD . Understanding the Early Signs of Chronic Disease by Investigating the Overlap of Mental Health Needs and Adolescent Obesity. AIMS Public Health, 2015, 2(3): 487-500. doi: 10.3934/publichealth.2015.3.487
    [3] Siti Roshaidai Mohd Arifin, Amalia Kamaruddin, Noor Azimah Muhammad, Mohd Said Nurumal, Hazwani Mohd Mohadis, Nik Hazlina Nik Hussain, Shanti Wardaningsih . An evaluation of digital intervention for perinatal depression and anxiety: A systematic review. AIMS Public Health, 2024, 11(2): 499-525. doi: 10.3934/publichealth.2024025
    [4] Amanda L. Divin, Keith J. Zullig . The Association between Non-Medical Prescription Drug Use and Suicidal Behavior among United States Adolescents. AIMS Public Health, 2014, 1(4): 226-240. doi: 10.3934/Publichealth.2014.4.226
    [5] James Matthews, Aidan P Moran, Amanda M Hall . The feasibility of a theory-based self-regulation intervention in schools to increase older adolescents’ leisure time physical activity behavior. AIMS Public Health, 2018, 5(4): 421-439. doi: 10.3934/publichealth.2018.4.421
    [6] Michael O Ogundele, Hani F Ayyash, Cornelius Ani . The impact of Covid-19 pandemic on services for children and adolescents with ADHD: results from a survey of paediatricians in the United Kingdom. AIMS Public Health, 2022, 9(3): 542-551. doi: 10.3934/publichealth.2022037
    [7] Nguyen Duc Thanh, Bui Tu Quyen, Truong Quang Tien . Validation of a Brief CES-D Scale for Measuring Depression and Its Associated Predictors among Adolescents in Chi Linh, Hai Duong, Vietnam. AIMS Public Health, 2016, 3(3): 448-459. doi: 10.3934/publichealth.2016.3.448
    [8] Sigma Bhattarai, Chet Kant Bhusal . Prevalence and associated factors of malnutrition among school going adolescents of Dang district, Nepal. AIMS Public Health, 2019, 6(3): 291-306. doi: 10.3934/publichealth.2019.3.291
    [9] Amna Salam Al-Wandi, Sarra Ibrahim Shorbagi . Sleep patterns and its relation to lifestyle habits: a study of secondary high school students in Sharjah, United Arab Emirates. AIMS Public Health, 2020, 7(3): 713-722. doi: 10.3934/publichealth.2020055
    [10] Allison DaSantos, Carlisle Goddard, Dalip Ragoobirsingh . Self-care adherence and affective disorders in Barbadian adults with type 2 diabetes. AIMS Public Health, 2022, 9(1): 62-72. doi: 10.3934/publichealth.2022006
  • Background 

    To address the problem of poor adherence among adolescents with perinatal HIV (PHIV), all clinics in Lesotho offer adolescent-friendly services and psychosocial support to improve their overall health outcomes and adherence. As a result, most adolescents with PHIV attend Teen Clubs as part of the package of youth-friendly HIV services. This study set out to determine whether attending Teen Clubs facilitates treatment adherence among adolescents with PHIV.

    Methods 

    In this cross-sectional study, data were collected from 130 adolescents aged 10–19 years who were aware of their HIV status and had attended three or more Teen Club sessions in selected clinics in rural district in Lesotho. Adherence was measured through self-report of last pills missed, based on the 7-days recall of pills taken. Descriptive statistics were used to analyse the data.

    Results 

    The median age of adolescents was 15 years, 56% were female, 37.7% were orphans, 41% were being cared for by their grandparents, 6.9% were living with siblings with no adult figure, and two were living on their own. The majority (93%) reported optimal adherence, 92% had not missed a clinic appointment in the past 30 days, and 74.4% knew that if they skipped doses, the viral load would increase and they would get sick. Over half (56%) had been reminded by their caregivers to take their medication and 96% talked to their caregivers regularly about their medication.

    Conclusion 

    A supportive environment provided through the Teen Clubs and in the home were the main facilitators for adherence. Strategies to improve adherence among adolescents should consider the importance of the involvement of caregivers in the adolescents' visits to their clinic.


    Abbreviations

    ART:

    antiretroviral therapy; 

    PHIV:

    perinatal HIV; 

    SRH:

    sexual and reproductive health; 

    SSA:

    sub-Saharan Africa

    Young people, including adolescents represent a growing share of people living with HIV worldwide [1] due to the increased success of antiretroviral therapy (ART). The adolescent epidemic is a global epidemic, since the majority of children with perinatal HIV (PHIV) are growing into adolescence and young adults [2]. Lesotho, a small, landlocked country in sub-Saharan Africa (SSA) has an adult prevalence estimated at 25.6% for the 15 to 49 years age group, and 2.1% of children in the 0 to 14 years age group live with HIV [1],[3]. With the success of ART, there has been an increasing number of children with PHIV who are maturing into adolescents, thereby increasing the population of those who are chronically ill [4].

    As ART access expands globally, adherence to a regimen of medication remains challenging [5]. Globally, adolescents with PHIV remain one of the population groups that has challenges in adhering to ART and their HIV-related complications continue to increase [6],[7]. Optimal adherence to ART is critical to the quality of life of children and adolescents with PHIV [8],[9]. Optimal ART adherence refers to taking medication as prescribed by the healthcare provider and attending clinic appointments and pharmacy refills as scheduled [10]. In the context of the universal test and treat strategy, ART adherence plays a key role in achieving the third “90”of the 90-90-90 strategy, which refers to the viral suppression of 90% of those on treatment [5]. Viral suppression is the ultimate goal and success of ART and is beneficial at both the individual and at the population level [11].

    Adherence to ART is a strong determinant of the disease outcome. ART prevents AIDS, its sequelae, and death only if adherence is near perfect and treatment is long-term [2],[7]. However, levels of adherence are reported to vary in different studies and countries. Some countries report significantly higher adherence rates in paediatric populations, and others state that the high rates are due to the level of support the adolescent receives [12],[13]. Additionally, levels of adherence differ among adolescent age groups, and those 15 years and older have a higher risk of poor adherence than younger adolescents do [6].

    Adherence is multifactorial, and the factors can be divided into those that hinder adherence and those that facilitate adherence. The factors include any combination of psychological, behavioral, environmental, and medication-related issues, which could explain why adolescents struggle with long-term adherence to ART [14][16]. Therefore, an understanding of the determinants of adherence is required in order to improve adherence and treatment outcomes [12]. Suboptimal adherence in adolescents is predicted by behavioral challenges such as peer pressure and concerns about body image [17]. Peer pressure and its effects are mostly felt in adolescence and can be the most important single determinant of adherence to PHIV. Adolescents with PHIV are also prone to treatment fatigue due to their having taken medication for a long time, sometimes since childhood, without ever seeing themselves as being sick [7]. Because ART requires near perfect adherence to be successful, adolescents with PHIV need support from their families, healthcare support, and psychosocial support that is given in terms of adherence sessions [4].

    To address the problem of poor adherence among HIV-positive adolescents and improve their overall health outcomes, all clinics in Lesotho offer HIV and ART adolescent-friendly services on weekdays as well as on Saturdays. A key strategy to ensure the effectiveness of adolescent-friendly services and to address adherence and retention in care of children and adolescents with PHIV is through Teen Clubs. The Teen Clubs are significant in Lesotho where a sizeable proportion of adolescents are on the second or and third line of ART drug regimens because of poor adherence. These are monthly ART clinics for adolescents (10–19 years old) that provide clinical services and peer psychosocial support. The Teen Club package provides adolescents with dedicated weekend clinic time with sexual and reproductive health (SRH) education, disclosure support, peer mentorship, and a positive space for peer interaction through facilitated sports, arts and games, life skills, and access to SRH services [18].

    Although the psychosocial Teen Clubs have been implemented in most clinics in Lesotho for more than four years [19], there are limited studies examining their effect on adherence. In countries where the Teen Club intervention has been introduced, a few studies have compared the retention rates between adolescents that were in a Teen Club and those in standard care [20],[21]. Data from a study conducted in Zimbabwe suggest that attending adolescents' specialised clinics improves adolescents' treatment outcomes. This study set out to determine whether attending psychosocial clubs facilitates ART adherence among adolescents with PHIV in Lesotho using self-reported accounts of adherence. Sub-optimal adherence is a major public health challenge, so understanding the adherence facilitators in this population could inform the design of interventions to improve adherence among HIV-positive adolescents [20].

    This cross-sectional study was conducted in nine adolescent-friendly clinics in the Mohale's hoek district of the Kingdom of Lesotho. The Kingdom of Lesotho is a landlocked country surrounded by South Africa. It is about 30,000 square kilometres in area and has an estimated population of 2.24 million. About 34% of the population live in urban areas and 66% in rural areas. Mohale's hoek is predominantly rural and mountainous, is located in the southern region of the Kingdom, and shares borders with South Africa. It has 15 health facilities, of which three are private clinics. The setting for the study was the 12 public facilities providing youth-friendly services, three of which were excluded from the study because they were hard to reach. The usual means of accessing them is via a helicopter or on horseback. The adolescent-friendly clinics provide services on weekdays and Saturdays for adolescents receiving ART. In addition, the clinics run Teen Clubs and offer a peer-support programme in which the facilitator is a trained healthcare worker such as a nurse, a counsellor, a social worker, or a peer educator. As already stated, the peer-support programme provides adolescents with counselling, addresses HIV knowledge, SRH education, adherence, disclosure, the acceptance of HIV status, and other psychosocial issues [18],[19].

    The study participants were all children and adolescents aged between 10–19 years who were receiving medical services and ART from the selected facilities. Approximately 800 children and adolescents were enrolled in these facilities, according to the district clinic statistics at the time of the data collection. Of these, 130 adolescents with PHIV aged between 10 and 19 years were recruited using the convenience sampling method. The research team was restricted to recruit on the days the selected clinics offer youth friendly services, which is Fridays and Saturdays. The adolescents attended the Teen Clubs once a month, mostly on Saturdays to avoid missing out on school. Participants were eligible to participate in the study if they were aware of their HIV status and had attended three or more teen club sessions at the time of the data collection. Knowing their HIV status was a requirement for enrolment in the Teen Clubs. The nurse clinicians referred eligible participants to the research team after consultation, and all recruitment was done in the mornings. For adolescents who were unaccompanied to the clinic by a caregiver, the research team had to visit the clinic twice. On the first visit, eligible adolescents were identified and on the second visit, the interview was conducted if the caregiver has given written consent. The study excluded adolescents who were behaviorally infected, those who were not aware of their HIV status, and those who had not participated in the Teen Clubs. Those who satisfied the inclusion criteria were invited to participate in the study.

    A researcher-administered tool adapted from the AIDS Clinical Trials Group [22] was used to measure the level of adherence to ART. The questions were divided into three sections: (i) socio-demographic characteristics, (ii) clinical information, and (iii) adherence questions. Clinical information included questions such as the duration on ART, the ART start date, and the number of pills. Adherence was measured through self-report of the last pills missed, based on the 30 days and 7 days recall of the pills taken (validated through the medical records). Variables assessing the family's characteristics included the type of caregiver-child relation and orphan status. The tool was semi-structured, translated into Sesotho, and researcher-administered. The second author of this paper and a trained research assistant collected data on the days when the Teen Club sessions were offered. Training for the research assistant on the purpose of the study, the tool, and confidentiality was done prior to data collection.

    The plan was to recruit only adolescents who were accompanied by caregivers for their routine appointments, but adolescents could come to the teen club sessions for ART refills unaccompanied. Since parental consent was required for those under the age of 18 years, the adolescents took information leaflets and consent forms home to obtain their caregivers' consent. Adolescents under the age of 18 years were interviewed only after obtaining caregivers written informed consent and their own written assent. The unavailability of caregivers to give consent in one clinic visit prolonged the data collection period to eight months since the research team had to visit clinics more than once to interview one participant. Written, informed consent was obtained from adolescents 18 years old and above. Informed consent and assent were administered in Sesotho. Face-to-face interviews with the participants were conducted in a private room in the absence of the parent/caregiver for those who had been accompanied to the clinic.

    After data cleaning and coding, Stata version 13 was used for analysis. Descriptive statistics were used to summarise the socio-demographic characteristics, the clinical characteristics, and the levels of adherence of the participants. All categorical variables were reported as absolute numbers and percentages. The means of continuous variables like age and the duration on ART were computed.

    Ethical approval was sought from the Research Ethics Committee of Sefako Makgatho Health Sciences University [SMUREC/H/257/2017: PG] and permission from the Ministry of Health, Lesotho [REF: ID: 46-2018] and the District Health Management Team. To minimize the pressure on the adolescents to participate, the researchers explained to them and the caregivers that participation was voluntary and that the adolescents could withdraw from the study at any stage.

    Table 1.  Characteristics of the study participants (n = 130).
    Variable Categories Freq. Percent (%)
    Gender Male 56 43
    Female 74 57
    Age category 10 years 3 2.3
    11–15 years 74 56.9
    16–19 years 53 40.8
    <15 years 77 59
    >15 years 53 41
    Schooling No 23 17.7
    Yes 107 82.3
    Walked to the clinic No 98 75.4
    Yes 49 24.6
    Caregiver employment status Employed 25 19.2
    Unemployed 100 76.9
    Pensioner 5 3.9
    Living arrangements Both parents 13 10
    Grandparents 26 26
    Mother 9 6.9
    Father 54 41.5
    Guardians 17 13.1
    Siblings 9 6.9
    Alone 2 1.5
    Mother alive Yes 81 62.3
    No 49 37.7
    Father alive Yes 53 41
    No 76 59
    Accompanied to clinic Yes 20 15.4
    No 110 84.6

     | Show Table
    DownLoad: CSV

    The characteristics of the participants are described in Table 1. All the participants were at the clinic for their ART refills, 56% were female, 84.6% were not accompanied to the clinic by adult caregivers, and only 24.6% had walked to the clinic while the majority 75% used public transport to get to their nearest clinic, and 82.3% were currently in school. These who had used transport to the clinics had paid an average of R14.00 ($0.89) per trip. The median age of the participants was 15 years (range 10–19 years) with 41% above 15 years old. The participants were asked about their living arrangements in order to identify their main caregivers. Most (41.5%) of them were living with their grandparents, 6.9% were living with their siblings with no adult figure in charge, and two were living alone. Those who were being cared for by their grandparents included most of the orphans and those whose parents worked far from home. Over three quarters (77%) of the caregivers were unemployed. The participants were asked about their biological parents to determine those maternally orphaned, as well as paternal orphans. The majority (62.3%) reported their mother to be still alive, while the mothers of 37.7% were deceased. The opposite was the case with the fathers: the majority (58.5%) reported their fathers deceased. One quarter (24.6%) of the participants were classified as double orphans. They had lost both parents (Table 1).

    The average number of tablets taken per day was two (range 1–9) and a significant proportion (n = 26, 20%) of the participants were taking more than three tablets per day and were on the second line and third line ART drug regimen. The majority (n = 50, 38.5%) of the participants had started taking ART between the ages of 11 and 15 years and the mean age of ART initiation was 9 years (SD = 5.8). Almost half (n = 63, 48.5%) had been receiving ART for not more than five years, the median time receiving ART was 4 years (SD = 4.19), 15.4% of the adolescents did not know when they had started ART, possibly because they had been receiving ART since birth.

    Table 2.  Adolescent's ART history.
    Variable Category Frequency Per cent
    Age ART initiation 1–5 years 17 13.1
    6–10 years 26 20
    11–15 years 50 38.5
    16–19 years 17 13.1
    Don't know 20 15.4
    Time on ART <1 year 11 8.5
    1–5 years 63 48.5
    6–10 years 25 19.3
    11–15 years 11 8.5
    >15 years 3 2.3
    Don't know 17 13.1
    Number of tablets 1 tablet 35 26.9
    2 tablets 48 36.9
    3 tables 21 16.2
    <3 tables 26 20

     | Show Table
    DownLoad: CSV

    Self-reported adherence was classified into optimal adherence, which correlates with missing zero to one dose on a seven-day missed dose recall (≥95%), non-adherence (less than 95%), or poor adherence, which correlates with missing two doses and more. The majority of the participating adolescents (83.1%, 108) reported no missed doses. Those who reported having missed doses within the seven days, 13 (10%) of them had missed one dose, 3 (2.3%) had missed two doses, 4 (3.1%) had missed three doses, and 2 (1.54%) had missed more than three doses. Those who missed doses cited lack of transport to collect ART (n = 3, 2.3%) and (n = 5, 3.6%) said they did not collect pills. The self-reported optimal adherence rate of the participants for the seven days recall was 93% and (6.9%) were non-adherent. The study did not find any association between non-adherence, gender, age, and duration on ART.

    Table 3.  Number missed ART doses in the past seven days.
    Frequency Percent
    Missed more than three days 2 1.54
    Missed three days 4 3.1
    Missed two days 3 2.3
    Missed one day 13 10
    Did not miss a dose 108 83.1
    Optimal adherence 121 93.1
    Non-adherence 9 6.9

     | Show Table
    DownLoad: CSV

    The majority (92.3%, 120) had not missed an ART clinic appointment in the past 30 days. Only 7.7% (10) reported to have missed an appointment, mainly due to lack of transport. Over half were reminded by their caregivers to take ART regularly and on time (n = 73, 56%), and over a third used cellphones as a reminder (n = 50, 38%) (Figure 1). Almost all (n = 125, 96.2%) talked to their caregivers about their medication.

    Figure 1.  Types of reminders to take ART on time.

    All the participants said they would not stop taking ART or purposefully skip taking ART. The most commonly described consequence of skipping ART was getting sick (n = 93, 74.4%), and a small proportion said they would die (n = 16, 12.8%). Similarly, the main reason given for adhering to their ART regimen was that the medication keeps them alive (n=105, 81.5%).

    Table 4.  Self-reported reasons for adherence.
    Reasons for not stopping to take ART Frequency Percent (%)
    The medication is my life and keeps me alive 57 49,6
    If I stop medication I will die 24 20.1
    If I stop medication I will get sick 16 13.5
    HIV and AIDS will multiply 20 16.8
    Perceived outcomes of skipping ART doses
    HIV will increase and I will get sick 93 74.4
    I will die 16 12.8
    I will lose weight 8 6.4
    CD4 will decrease 7 6.4

     | Show Table
    DownLoad: CSV

    This study assessed ART adherence among adolescents attending psychosocial Teen Clubs in rural Lesotho. The study found that 37.7% of the adolescents were maternal orphans, 41.5% were being cared for by their grandparents, and 77% of the caregivers were unemployed. The study showed that the mean age of enrolment in care was 15 years, and over half (51.6%) of the adolescents had been initiated on ART between the ages of 11 and 19 years. The findings are in keeping with those of other studies, both on the late diagnosis of HIV and late enrolment in care among the growing population of adolescents with PHIV [23],[24]. The reasons for the late initiation of ART in adolescents with PHIV, as noted in other studies, were fear, stigma, and waiting for clinical symptoms to appear [24][26]. The study further found that the mean duration on ART was four years, but three-quarters (70.1%) of the adolescents had been receiving ART for more than five years (range 5–15 years). A significant proportion (20%) of the participating adolescents were taking more than three tablets per day.

    All the participants had been disclosed to fully and they were attending Teen Clubs at the time of the data collection. Although the current study did not collect data on the age when the participants received disclosure, research shows that full disclosure is often delayed until the child is above ten years old. In a study conducted in South Africa, Madiba and Mokgatle [26] found that disclosure occurred between 10 and 16 years of age. The mean age of initiation on ART in the current study suggests that the participants were disclosed to late in adolescence, possibly at the time when they were initiated on ART, between the ages of 11 and 15 years. Delayed disclosure has been associated with suboptimal adherence to treatment, poor health outcomes, virologic failure, and the need for more complex regimens [27],[28]. Clinical data from the study setting show that most adolescents are on the second line and third line regimen, following episodes of poor adherence. Hence, the attendance of Teen Clubs and the provision of adherence counselling has been adopted in Lesotho as standard care for children and adolescents with PHIV.

    Good self-reported optimal adherence in the seven-day recall was reported by the participants, with 93% reporting optimal adherence. Concerning missing clinic appointments, 92% had not missed an appointment in the past 30 days. The results suggest that attendance of a psychosocial club is protective against non-adherence. The potential association between adherence and the attendance of psychosocial group sessions led by a professional facilitator had been documented [28]. The warm acceptance by and support of health care workers at treatment sites improve their adherence both to clinic visits and to their medical regimen [13]. It should be noted that a significant proportion (20%) of the participating adolescents were taking more than three tablets per day, up to nine tablets. Some of these adolescents could not benefit from the fixed dose formulations because they were switched to the second line and third line ART regimen due to poor virological outcomes before enrollment in the Teen Clubs. Recent data from Malawi suggest that exposure to Teen Clubs facilitates adherence, as these clinics serve as a resource for health education and psychosocial support for the adolescents [20]. The continuous information the HCWs give adolescents regarding the HIV illness and their medication facilitates adherence [13].

    All the participants in the current study said that they would not intentionally stop taking their ART medication altogether. Half of them (49.6%) said they would not stop because ART keeps them alive, 20% said if they stopped taking medication they would die, 13.5% said that without their medication they would get sick, and 16.8% said that the prevalence of HIV and AIDS would increase. Research suggest that adhering to ART requires that the adolescents understand why they have to take ART, how it works, and how it benefits them [29]. Gross et al. [28] found that the comfort the adolescents feel in asking questions of the health provider and participating in group sessions was significantly associated with excellent adherence.

    The study found that the adolescents had a comprehensive understanding of the negative outcomes of skipping doses of ART. Three quarters (74.4%) of them knew that if they skipped doses, their viral load would increase and they would get sick. A study conducted in Ghana reported similar findings [30]. Other studies have emphasised that adolescents' knowledge of the HIV disease is a strong determinant of adherence [31],[32]. In a study conducted in Botswana, Madiba and Josiah [16] found that comprehensive understanding of ART medication was a facilitator for adherence among adolescents with PHIV.

    Although only 56% of the participants were being reminded by their caregivers to take their medication on time, other direct involvement of caregivers with the medication was observed. Majority (93%) had regular discussions with their caregivers about their medication. In this study, as in others, being reminded to take the medication on time, having regular discussions about the medication, and having the reason for taking the medication consistently explained were facilitators of adherence [16]. The role of social support especially from family members in influencing adherence outcomes has been reported elsewhere [7],[33]. The current study found that 84.6% of the participants had not been accompanied to the clinic by their adult caregivers, but having someone accompany them to the clinic and related good adherence is reported in other studies [16],[28]. The findings from this study and others underscore the need to include caregivers in interventions aiming at increasing ART adherence among adolescents with PHIV [33],[34]. Furthermore, the use of cell-phone reminders has been found to improve self-reported adherence among adolescents with PHIV in this study as well as in others [28],[30].

    Our study employed self-report to measure ART adherence and being subject to social desirability, self-reports can overestimate adherence. Other methods that could be used to assess the level of adherence are viral load measures, but viral load monitoring in this population is poor due to attendance of Teen Clubs on weekends when laboratories and transportation is not available. Therefore, assessing short-term adherence provides a measure that could inform interventions to improve adherence among adolescents with PHIV in poor resourced settings and hard to reach populations such as Lesotho. Nevertheless, viral load measures remain important measures of optimal adherence. The study is further subject to selection bias because of the use of convenience sampling, the exclusion of adolescents for whom disclosure has not occurred, and exclusion of three hard-to-reach facilities. Adolescents in these facilities might have different experiences of the Teen Clubs. These render the findings unbefitting of being generalised to other populations of adolescents. The lack of comparison data is a limitation and there is a need for the performance of further studies that use a combination of measures of adherence among this population group using comparative data with adolescents who are not attending psychosocial Teen Clubs. Currently there is little consensus on what factors contribute most to ART adherence in children and adolescents in SSA.

    A high proportion of the participants reported optimal adherence despite some of them being on complex drug regimens. The study found that a supportive environment provided through the Teen Clubs played a significant role in improving adherence. The participants had been enrolled in Teen Clubs as part of a package of adolescent-friendly services and psychosocial support to improve adherence following episodes of poor adherence. The participants had strong adherence, high knowledge of the importance of ART as well as family support.

    Strategies to improve adherence among adolescents with PHIV should consider the importance of the involvement of caregivers in the adolescents' visits to their clinics. At the same time, the provision of professional-led Teen Clubs should be strengthened as a form of treatment support. In addition, future research should explore the adherence of those who do not attend the Teen Clubs to investigate the role of the caregivers in facilitating adherence in adolescents with a history of poor adherence.


    Acknowledgments



    The authors appreciate the facility staff for their assistance and support. We would like to thank you for following the instructions above very closely in advance. These two authors contributed equally.

    Conflict of interest



    The authors declare no conflict of interest.

    [1] UNICEF (2019) Adolescent HIV prevention. Turning the tide against will require more concentrated focus on adolescents and young people Available from: https://www.data.unicef.org/tpoic/hivaids/adolescents-young-people.
    [2] Denison JA, Banda H, Dennis AC, et al. (2015) “The sky is the limit”: adhering to antiretroviral therapy and HIV self-management from the perspectives of adolescents living with HIV and their adult caregivers. J Int AIDS Soc 18: e19358. doi: 10.7448/IAS.18.1.19358
    [3] LePHIA (2017)  Lesotho Population Based HIV Impact Assessment (2016–2017) Maseru, Lesotho: Ministry of Health, Available from: https://phia.icap.columbia.edu/wp-content/uploads/2018/02/Lesotho-Summary-Sheet_A4.2.7.18.HR_.pdf.
    [4] Hawkins A, Evangeli M, Sturgeon K, et al. (2016) Episodic medication adherence in adolescents and young adults with perinatally acquired HIV: a within-participants approach. AIDS Care 28: 68-75. doi: 10.1080/09540121.2016.1146210
    [5] Haberer JE, Sabin L, Amico KR, et al. (2017) Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations. J Int AIDS Soc 20: e21371. doi: 10.7448/IAS.20.1.21371
    [6] Adejumo OA, Malee KM, Ryscavage P, et al. (2015) Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review. J Int AIDS Soc 18: e20049. doi: 10.7448/IAS.18.1.20049
    [7] Inzaule SC, Hamers RL, Kityo C, et al. (2016) Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study. PLoS One 11: e0167492. doi: 10.1371/journal.pone.0167492
    [8] Kalomo EN, Liao M, Besthorn F, et al. (2017) To tell or not to tell: Dimensions of disclosure to children with HIV in the Zambezi region of Northern Namibia. J HIV AIDS Soc Serv 16: 250-268. doi: 10.1080/15381501.2017.1341359
    [9] Kiwanuka J, Mulogo E, Haberer JE (2014) Caregiver Perceptions and Motivation for Disclosing or Concealing the Diagnosis of HIV Infection to Children Receiving HIV Care in Mbarara, Uganda: A Qualitative Study. PLoS One 9: e93276. doi: 10.1371/journal.pone.0093276
    [10] Vreeman RC, Nyandiko WM, Liu H, et al. (2014) Measuring adherence to antiretroviral therapy in children and adolescents in western Kenya. J Int AIDS Soc 17: e19227. doi: 10.7448/IAS.17.1.19227
    [11] Iacob SA, Iacob DG, Jugulete G (2017) Improving the adherence to antiretroviral therapy, a difficult but essential task for a successful HIV treatment—clinical points of view and practical considerations. Front Pharmacol 8: e831. doi: 10.3389/fphar.2017.00831
    [12] Haberer JE, Cook A, Walker AS, et al. (2011) Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects. PloS One 6: e18505. doi: 10.1371/journal.pone.0018505
    [13] Nglazi MD, Kranzer K, Holele P, et al. (2012) Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South Africa. BMC Infect 12: 1-7. doi: 10.1186/1471-2334-12-1
    [14] Agwu AL, Fairlie L (2013) Antiretroviral treatment, management challenges and outcomes in perinatally HIV-infected adolescents. J Int AIDS Soc 16: e18579. doi: 10.7448/IAS.16.1.18579
    [15] Bukenya D, Mayanja BN, Nakamanya S, et al. (2019) What causes non-adherence among some individuals on long term antiretroviral therapy? Experiences of individuals with poor viral suppression in Uganda. AIDS Res Ther 16: 1-9. doi: 10.1186/s12981-018-0214-y
    [16] Madiba S, Josiah U (2019) Perceived Stigma and Fear of Unintended Disclosure are Barriers in Medication Adherence in Adolescents with Perinatal HIV in Botswana: A Qualitative Study. Biomed Res Int e9623159.
    [17] Ankrah DN, Koster ES, Mantel-Teeuwisse AK, et al. (2016) Facilitators and barriers to antiretroviral therapy adherence among adolescents in Ghana. Patient Prefer Adherence 10: 329-337. doi: 10.2147/PPA.S96691
    [18] WHO (2019) Adolescent friendly health services for adolescents living with HIV: from theory to practice. Technical Brief Geneva, Switzerland: World Health Organization, Available from: https://apps.who.int/iris/bitstream/handle/10665/329993/WHO-CDS-HIV-19.39-eng.pdf.
    [19] EGPAF (2017) A tool to enhancetreatment for adolescents and young people living with HIV in Lesotho. Elizabeth Glaser Pediatric AIDS Foundation Available from: https://www.pedaids.org/wp-content/uploads/2018/04/EGPAF-Lesotho-Peer-Support-Group-Guide-PSC-approved_July-2017.pdf.
    [20] McBride K, Parent J, Mmanga K, et al. (2019) ART adherence among Malawian youth enrolled in teen clubs: a retrospective chart review. AIDS Behav 23: 2629-2633. doi: 10.1007/s10461-019-02580-y
    [21] Munyayi FK, van Wyk BE (2020) The Comparison of Teen Clubs vs. Standard Care on Treatment Outcomes for Adolescents on Antiretroviral Therapy in Windhoek, Namibia. AIDS Res Ther e8604276.
    [22] Chesney MA, Ickovics J, Chambers D, et al. (2000) Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. AIDS Care 12: 255-266. doi: 10.1080/09540120050042891
    [23] Ferrand RA, Luethy R, Bwakura F, et al. (2007) HIV infection presenting in older children and adolescents: a case series from Harare, Zimbabwe. Arch Clin Infect Dis 44: 874-878. doi: 10.1086/511878
    [24] Mokgatle MM, Madiba S (2015) The burden of disease on HIV-infected orphaned and non-orphaned children accessing primary health facilities in a rural district with poor resources in South Africa: a cross-sectional survey of primary caregivers of HIV-infected children aged 5–18 years. Infect Dis Poverty 4: 1-13. doi: 10.1186/s40249-015-0049-x
    [25] Boender TS, Sigaloff KC, Kayiwa J, et al. (2012) Barriers to initiation of pediatric HIV treatment in Uganda: a mixed-method study. AIDS Res Ther e817506.
    [26] Madiba S, Mokgatle M (2017) Fear of stigma, beliefs, and knowledge about HIV are barriers to early access to HIV testing and disclosure for perinatally infected children and adolescents in rural communities in South Africa. S Afr Fam Pract 59: 175-181. doi: 10.1080/20786190.2017.1329489
    [27] Lowenthal ED, Jibril HB, Sechele ML, et al. (2014) Disclosure of HIV status to HIV-infected children in a large African treatment center: Lessons learned in Botswana. Child Youth Serv Rev 45: 143-149. doi: 10.1016/j.childyouth.2014.03.031
    [28] Gross R, Bandason T, Langhaug L, et al. (2015) Factors associated with self-reported adherence among adolescents on antiretroviral therapy in Zimbabwe. AIDS Care 27: 322-326. doi: 10.1080/09540121.2014.969676
    [29] WHO (2014)  Adolescent HIV Testing, Counselling And Care: Implementation Guidelines For Health Providers And Planners Geneva, Switzerland: Available from: http://apps.who.int/iris/bitstream/handle/10665/94334/9789241506168_eng.pdf?sequence=1.
    [30] Ankrah DN, Koster ES, Mantel-Teeuwisse AK, et al. (2016) Facilitators and barriers to antiretroviral therapy adherence among adolescents in Ghana. Patient Prefer Adherence 10: 329-337. doi: 10.2147/PPA.S96691
    [31] Madiba S, Mokgatle M (2016) Perceptions and Experiences about Self-Disclosure of HIV Status among Adolescents with Perinatal Acquired HIV in Poor-Resourced Communities in South Africa. AIDS Res Ther e2607249.
    [32] Nabukeera-Barungi N, Elyanu P, Asire B, Katureebe C, et al. (2015) Adherence to antiretroviral therapy and retention in care for adolescents living with HIV from 10 districts in Uganda. BMC Infect 15: 1-10. doi: 10.1186/s12879-014-0722-x
    [33] Damulira C, Mukasa MN, Byansi W, et al. (2019) Examining the relationship of social support and family cohesion on ART adherence among HIV-positive adolescents in southern Uganda: baseline findings. Vulnerable Child Youth Stud 14: 181-190. doi: 10.1080/17450128.2019.1576960
    [34] Nabunya P, Bahar OS, Chen B, et al. (2020) The role of family factors in antiretroviral therapy (ART) adherence self-efficacy among HIV-infected adolescents in southern Uganda. BMC Public Health 20: 1-9. doi: 10.1186/s12889-019-7969-5
  • This article has been cited by:

    1. Rirhandzu Austice Mabasa, Sphiwe Madiba, Tebogo Maria Mothiba, Structural, Familial, and Psychosocial Factors Affecting Long-Term Antiretroviral Treatment Adherence amongst Adolescents Living with Perinatally Acquired HIV in Limpopo, South Africa, 2023, 20, 1660-4601, 7074, 10.3390/ijerph20227074
    2. Rirhandzu A. Mabasa, Linda Skaal, Tebogo M. Mothiba, Social support experiences of adolescents living with perinatal HIV in rural Limpopo, South Africa, 2024, 25, 2078-6751, 10.4102/sajhivmed.v25i1.1521
    3. Charisse V. Ahmed, Rebecca Doyle, Darby Gallagher, Olore Imoohi, Ugochi Ofoegbu, Robyn Wright, Mackensie A. Yore, Merrian J. Brooks, Dalmacio Dennis Flores, Elizabeth D. Lowenthal, Bridgette M. Rice, Alison M. Buttenheim, A Systematic Review of Peer Support Interventions for Adolescents Living with HIV in Sub-Saharan Africa, 2023, 37, 1087-2914, 535, 10.1089/apc.2023.0094
    4. Rachel Chamanga, Tessa Musukwa, Louiser Kalitera, Felix Gent, Harrid Nkhoma, Kwashie Kudiabor, Alice Maida, Dumbani Kayira, Verita Buie, Godfrey Woelk, Thulani Maphosa, Examining teen club attendance and viral load suppression among adolescents under differentiated HIV care in Malawi: a sub-optimal scenario, 2024, 24, 1471-2458, 10.1186/s12889-024-21109-0
  • Reader Comments
  • © 2021 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(4742) PDF downloads(84) Cited by(4)

Figures and Tables

Figures(1)  /  Tables(4)

Other Articles By Authors

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog